Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical    ISRG

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Intuitive Surgical, Inc. : Intuitive Surgical 1Q Profit Up 38% On Strong Revenue

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2012 | 12:14am CEST

--Intuitive Surgical tops first-quarter sales and earnings estimates

--Sales of da Vinci systems, procedure growth, fuel gains

--Company raises full-year guidance for sales, procedure growth

(Updates throughout with details on results and outlook)

 
   By Jon Kamp 
   Of  
 

Intuitive Surgical Inc.'s (ISRG) first-quarter earnings rose 38%, beating Wall Street expectations behind climbing sales of the company's da Vinci robotic-surgery machines and growth in procedures.

The Sunnyvale, Calif., company boosted its full-year forecasts for both revenue and procedure growth following the strong quarterly report. Shares--which are trading near all-time high levels and have climbed 18% on the year through Tuesday's close--rose 5.8%, to $576.98 in after-hours trading.

The company's motion-capture robots, which have been heavily used for cancer-treating surgeries, such as hysterectomies and prostate removal, have remained in strong demand despite continued economic turbulence and some sluggishness in Europe. The company sold 140 machines in the recent quarter, up 20 from a year ago, and posted 29% growth in procedures.

The company saw strong growth in both general-surgery and gynecological procedures, Chief Executive Gary Guthart said on a conference call with analysts. Newly introduced da Vinci instruments also helped fuel rising sales.

Intuitive Surgical reported a profit of $143.5 million, or $3.50 a share, up from $104.1 million, or $2.59 a share, a year earlier. Revenue increased 28%, to $495.2 million.

Analysts polled by Thomson Reuters most recently projected earnings of $3.14 on revenue of $464.7 million.

Gross margin edged up to 71.9% from 71.8%.

Revenue from instruments and accessories climbed 32%, reflecting growth in da Vinci procedures and the roll-out of new products. Revenue from service deals for da Vinci machines jumped 27%. Systems revenue, reflecting newly sold machines, grew 24%.

Da Vinci systems sold for nearly $1.5 million, on average, in the recent quarter.

Despite the overall strong sales, company officials said system sales in Europe were disappointing and below historical trends. They indicated the company is working to bolster its marketing efforts there.

"European system sales reflect a challenging economic environment, however, we are also taking steps to improve our execution," Chief Financial Officer Marshall Mohr said on the conference call.

Looking ahead, Intuitive Surgical now anticipates revenue growth of 19% to 21% this year, up from the company's prior 17% to 19% forecast. The company's new guidance calls for procedure growth of 25% to 27%, up from the prior 24% to 26% target.

Analysts had forecast, on average, sales growth of about 18% this year.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; [email protected]

--Tess Stynes contributed to this article.

Order free Annual Report for Intuitive Surgical, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US46120E6023 or call +44 (0)208 391 6028

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL
06/10 INTUITIVE SURGICAL : $2.35 Million Federal Contract Awarded to Intuitive Surgica..
06/09 INTUITIVE SURGICAL : Reports New Employee Option Grants for June 2017
06/08 Intuitive Surgical Reports New Employee Option Grants for June 2017
05/31 INTUITIVE SURGICAL : Receives FDA Clearance for Latest da Vinci Robotic-Assisted..
05/30 Intuitive Surgical Receives FDA Clearance for Latest da Vinci® Robotic-Assist..
05/12 Intuitive Surgical Reports New Employee Option Grants for May 2017
05/11 INTUITIVE SURGICAL : Patent Issued for Retraction of Tissue for Single Port Entr..
05/11 INTUITIVE SURGICAL : Researchers Submit Patent Application, "Surgical System Inc..
05/11 INTUITIVE SURGICAL : Patent Application Titled "Ratcheting for Master Alignment ..
05/05 INTUITIVE SURGICAL : Combine Solicitation - One-time repair/replace service
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06:59aDJROYAL PHILIPS : Philips Buys CardioProlific Inc for Undisclosed Sum
06/28 Philips to buy medical device maker Spectranetics for 1.9 billion euros
06/28DJROYAL PHILIPS : to Buy Spectranetics for $2.15 Billion
06/22DJROYAL PHILIPS : Philips to Buy Electrical Geodesics for GBP29 Million
06/19 PERKINELMER : to buy Germany's Euroimmun for about $1.3 billion
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
06/12 VALUATION DASHBOARD : Healthcare - Update
06/09 Focus On Growth And Value - Cramer's Mad Money (6/8/17)
06/08 15 Stocks To Buy On Market Weakness - Cramer's Mad Money (6/7/17)
06/07 INTUITIVE SURGICAL : The Robots Are Taking Over
06/01 X Marks The Spot For Intuitive Surgical
Advertisement
Financials ($)
Sales 2017 2 965 M
EBIT 2017 1 194 M
Net income 2017 769 M
Finance 2017 2 132 M
Yield 2017 -
P/E ratio 2017 45,98
P/E ratio 2018 39,51
EV / Sales 2017 11,0x
EV / Sales 2018 9,64x
Capitalization 34 863 M
More Financials
Chart INTUITIVE SURGICAL
Duration : Period :
Intuitive Surgical Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Full-screen chart
Technical analysis trends INTUITIVE SURGICAL
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 884 $
Spread / Average Target -6,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Alan J. Levy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL49.22%34 863
THERMO FISHER SCIENTIF..23.10%68 765
DANAHER8.84%60 020
BOSTON SCIENTIFIC CORP..30.00%38 508
ROYAL PHILIPS12.21%34 293
ILLUMINA37.74%26 480
More Results